Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Review Article
Authors: Medoro, Alessandroa; 1 | Bartollino, Silviaa; 1 | Mignogna, Donatellaa | Passarella, Danielaa | Porcile, Carolaa | Pagano, Aldob | Florio, Tullioc | Nizzari, Marioc | Guerra, Germanoa | Di Marco, Robertoa | Intrieri, Marianoa | Raimo, Gennaroa | Russo, Claudioa; *
Affiliations: [a] Department of Medicine and Health Sciences “V. Tiberio”, University of Molise, Campobasso, Italy | [b] Department of Experimental Medicine, University of Genoa and Ospedale Policlinico San Martino, IRCCS per l’Oncologia, Genoa, Italy | [c] Department of Internal Medicine and Centre of Excellence for Biomedical Research, University of Genoa, Genoa, Italy
Correspondence: [*] Correspondence to: Prof. Claudio Russo, Department of Medicine and Health Sciences “V. Tiberio”, University of Molise, Via F. De Sanctis, 86100 Campobasso, Italy. Tel.: +39 0874404897; E-mail: [email protected].
Note: [1] These authors contributed equally to this work.
Abstract: The processing of the amyloid-β protein precursor (AβPP) by β- and γ-secretases is a pivotal event in the genesis of Alzheimer’s disease (AD). Besides familial mutations on the AβPP gene, or upon its overexpression, familial forms of AD are often caused by mutations or deletions in presenilin 1 (PSEN1) and 2 (PSEN2) genes: the catalytic components of the proteolytic enzyme γ-secretase (GS). The “amyloid hypothesis”, modified over time, states that the aberrant processing of AβPP by GS induces the formation of specific neurotoxic soluble amyloid-β (Aβ) peptides which, in turn, cause neurodegeneration. This theory, however, has recently evidenced significant limitations and, in particular, the following issues are debated: 1) the concept and significance of presenilin’s “gain of function” versus “loss of function”; and 2) the presence of several and various GS substrates, which interact with AβPP and may influence Aβ formation. The latter consideration is suggestive: despite the increasing number of GS substrates so far identified, their reciprocal interaction with AβPP itself, even in the AD field, is significantly unexplored. On the other hand, GS is also an important pharmacological target in the cancer field; inhibitors or GS activity are investigated in clinical trials for treating different tumors. Furthermore, the function of AβPP and PSENs in brain development and in neuronal migration is well known. In this review, we focused on a specific subset of GS substrates that directly interact with AβPP and are involved in its proteolysis and signaling, by evaluating their role in neurodegeneration and in cell motility or proliferation, as a possible connection between AD and cancer.
Keywords: Alzheimer’s disease, AβPP, β-secretase, cancer, cell migration, γ-secretase, LDL receptor, Notch
DOI: 10.3233/JAD-170628
Journal: Journal of Alzheimer's Disease, vol. 61, no. 1, pp. 1-15, 2018
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]